179 related articles for article (PubMed ID: 37004177)
1. Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis.
Ekman D; Sennblad B; Knight A; Karlsson Å; Rantapää-Dahlqvist S; Berglin E; Stegmayr B; Baslund B; Palm Ø; Haukeland H; Gunnarsson I; Bruchfeld A; Segelmark M; Ohlsson S; Mohammad AJ; Svärd A; Pullerits R; Herlitz H; Söderbergh A; Omdal R; Jonsson R; Rönnblom L; Eriksson P; Lindblad-Toh K; Dahlqvist J
Rheumatology (Oxford); 2023 Sep; 62(9):3213-3218. PubMed ID: 37004177
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA.
Dahlqvist J; Ekman D; Sennblad B; Kozyrev SV; Nordin J; Karlsson Å; Meadows JRS; Hellbacher E; Rantapää-Dahlqvist S; Berglin E; Stegmayr B; Baslund B; Palm Ø; Haukeland H; Gunnarsson I; Bruchfeld A; Segelmark M; Ohlsson S; Mohammad AJ; Svärd A; Pullerits R; Herlitz H; Söderbergh A; Rosengren Pielberg G; Hultin Rosenberg L; Bianchi M; Murén E; Omdal R; Jonsson R; Eloranta ML; Rönnblom L; Söderkvist P; Knight A; Eriksson P; Lindblad-Toh K
Rheumatology (Oxford); 2022 Aug; 61(8):3461-3470. PubMed ID: 34888651
[TBL] [Abstract][Full Text] [Related]
3. The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population.
Lundtoft C; Knight A; Meadows JRS; Karlsson Å; Rantapää-Dahlqvist S; Berglin E; Palm Ø; Haukeland H; Gunnarsson I; Bruchfeld A; Segelmark M; Ohlsson S; Mohammad AJ; Eriksson P; Söderkvist P; Ronnblom L; Omdal R; Jonsson R; Lindblad-Toh K; Dahlqvist J
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38580345
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
5. Association of
Kawasaki A; Sada KE; Kusumawati PA; Hirano F; Kobayashi S; Nagasaka K; Sugihara T; Ono N; Fujimoto T; Kusaoi M; Tamura N; Kusanagi Y; Itoh K; Sumida T; Yamagata K; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
Front Immunol; 2023; 14():1119064. PubMed ID: 36969218
[TBL] [Abstract][Full Text] [Related]
6. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
[TBL] [Abstract][Full Text] [Related]
7. HLA-DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Cohort Study.
Hilhorst M; Arndt F; Joseph Kemna M; Wieczorek S; Donner Y; Wilde B; Thomas Epplen J; van Paassen P; Cohen Tervaert JW
Arthritis Rheumatol; 2016 Jul; 68(7):1721-30. PubMed ID: 26866715
[TBL] [Abstract][Full Text] [Related]
8. PR3-ANCA-associated vasculitis is associated with a specific motif in the peptide-binding cleft of HLA-DP molecules.
Gregersen JW; Erikstrup C; Ivarsen P; Glerup R; Krarup E; Keller KK; Hansen IT; Møller BK
Rheumatology (Oxford); 2019 Nov; 58(11):1942-1949. PubMed ID: 30938436
[TBL] [Abstract][Full Text] [Related]
9. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
[TBL] [Abstract][Full Text] [Related]
10. Distinct HLA and non-HLA associations in different subtypes of ANCA-associated vasculitides in North India.
Singh J; Sharma A; Rani L; Kaur N; Anand S; Saikia B; Jha S; Nada R; Minz RW
Int J Rheum Dis; 2020 Jul; 23(7):958-965. PubMed ID: 32297471
[TBL] [Abstract][Full Text] [Related]
11. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
Mohammad AJ; Segelmark M
J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
[TBL] [Abstract][Full Text] [Related]
12. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
[TBL] [Abstract][Full Text] [Related]
13. Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.
Berglin E; Mohammad AJ; Dahlqvist J; Johansson L; Eriksson C; Sjöwall J; Rantapää-Dahlqvist S
J Autoimmun; 2021 Feb; 117():102579. PubMed ID: 33340843
[TBL] [Abstract][Full Text] [Related]
14. Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis.
Pearce FA; Craven A; Merkel PA; Luqmani RA; Watts RA
Rheumatology (Oxford); 2017 Nov; 56(11):1962-1969. PubMed ID: 28968886
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
[TBL] [Abstract][Full Text] [Related]
17. Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge.
Bonaci-Nikolic B; Andrejevic S; Pavlovic M; Dimcic Z; Ivanovic B; Nikolic M
Clin Rheumatol; 2010 Aug; 29(8):893-904. PubMed ID: 20306213
[TBL] [Abstract][Full Text] [Related]
18. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Wu EY; McInnis EA; Boyer-Suavet S; Mendoza CE; Aybar LT; Kennedy KB; Poulton CJ; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Nachman PH; Jennette JC; Falk RJ; Bunch DO
Arthritis Rheumatol; 2019 Nov; 71(11):1894-1903. PubMed ID: 31215772
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
Bornstein G; Ben-Zvi I; Furie N; Grossman C
Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
[TBL] [Abstract][Full Text] [Related]
20. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.
Lionaki S; Blyth ER; Hogan SL; Hu Y; Senior BA; Jennette CE; Nachman PH; Jennette JC; Falk RJ
Arthritis Rheum; 2012 Oct; 64(10):3452-62. PubMed ID: 23023777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
